login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Avinger’s Ocelot catheter is CE marked


Thursday, 29 Sep 2011 11:21

Avinger has received CE mark approval for Ocelot ― a peripheral catheter system used with real-time Optical Coherence Tomography (OCT) for the treatment of peripheral artery disease.


According to Avinger, medical professionals, for the first time ever, will have access to a therapeutic device that incorporates real time intravascular guidance by using Ocelot’s Lightbox console as an adjunct to fluoroscopy.


“Ocelot CE mark is a long anticipated milestone for Avinger and a much larger milestone for me professionally. I have been working on uniting intravascular guidance with therapeutic products for 30 years and I am humbled that we have been able to achieve this at Avinger,” said John B Simpson, Avinger’s founder and CEO.


Avinger is currently enrolling patients in the VISTA study ― a single-centre, non-randomised registry designed to evaluate the safety and efficacy of Ocelot in patients with peripheral artery disease. The registry is being developed in Paraguay, with Adrian Ebner of Sanitorio Italiano in Asunción, as the principal investigator.


European comercialisation of Ocelot has already begun. The first three commercial cases are scheduled to be performed in Italy and Germany in late September and early October.

 




Add New Comment

Most popular


Monday, 14 Mar 2016
Although systemic thrombolysis achieves similar rates of mortality as catheter-directed intervention for the treatment of acute pulmonary embolism, it also carries “significantly increased odds of ... Systemic thrombolysis for acute pulmonary embolism increases stroke risk compared with catheter-directed intervention

Silk Road Medical receives CE mark for next-generation Enroute transcarotid neuroprotection system
Wednesday, 16 Mar 2016
Silk Road Medical has been granted CE approval for its Enroute transcarotid neuroprotection system (NPS). The company has also reported the first patients have been treated with the system. Silk Road Medical receives CE mark for next-generation Enroute transcarotid neuroprotection system

FDA proposes ban on most powdered medical gloves
Tuesday, 22 Mar 2016
The US Food and Drug Administration has announced a proposal to ban most powdered gloves in the USA. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness ... FDA proposes ban on most powdered medical gloves

Features


A research track record helps physicians assess new technology
Tuesday, 12 Apr 2016
Scott Trerotola, Stanley Baum Professor and chief, Vascular and Interventional Radiology, University of Pennsylvania Medical Center, Philadelphia, USA, delivered the Dr Charles T Dotter Lecture at ... A research track record helps physicians assess new technology

How we innovate must change dramatically
Friday, 01 Apr 2016
In order to fully capitalise on the potential of advances in materials, drugs, biologics, sensing, informatics, guidance, manufacturing processes and marketing, an organised collaborative approach to ... How we innovate must change dramatically

Profiles


Gabriel Bartal
Thursday, 26 Nov 2015
“In the early days, I used to have to cut a 7F plastic tube, make side holes, send it off for ... Gabriel Bartal

Lindsay Machan
Thursday, 28 May 2015
“Focusing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions